2023
DOI: 10.1093/brain/awad285
|View full text |Cite
|
Sign up to set email alerts
|

Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severity

Susan X N Lin,
Philip K Ahring,
Angelo Keramidas
et al.

Abstract: Genetic variants associated with developmental and epileptic encephalopathies have been identified in the GABRB3 gene that encodes the β3 subunit of GABAA receptors. Typically, variants alter receptor sensitivity to GABA resulting in either gain- or loss-of-function, which correlates with patient phenotypes. However, it is unclear how another important receptor property, desensitization, contributes to the greater clinical severity of gain-of-function variants. Desensitization properties of 20 g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 46 publications
0
3
0
Order By: Relevance
“…Recently, we reported that more severe phenotypes observed in individuals with GABRB3 GOF variants in M1 could be attributed to decreased receptor desensitisation. 36 In the GABRB2 Low-shift GOF group, one individual (#18) harboured the L255V variant, which is a paralogue of the GABRB3 L256Q variant previously shown to cause decreased desensitisation. This individual suffered from treatment-resistant epilepsy with severe movement disorders and moderate developmental delay, ultimately succumbing to SUDEP at the age of 4 years.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Recently, we reported that more severe phenotypes observed in individuals with GABRB3 GOF variants in M1 could be attributed to decreased receptor desensitisation. 36 In the GABRB2 Low-shift GOF group, one individual (#18) harboured the L255V variant, which is a paralogue of the GABRB3 L256Q variant previously shown to cause decreased desensitisation. This individual suffered from treatment-resistant epilepsy with severe movement disorders and moderate developmental delay, ultimately succumbing to SUDEP at the age of 4 years.…”
Section: Resultsmentioning
confidence: 99%
“…For desensitisation experiments, another setup with ultra-low bath volumes was used to ensure rapid liquid exchange. 36 3 M KCl-filled borosilicate glass microelectrodes with resistance of 0.2–1.6 MΩ were inserted into cells then clamped at −60 mV with constant perfusion of ND96 solution (96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, 1.8 mM CaCl 2 , pH 7.4) through a gravity-driven semi-automatic system at 1 mL/min. A Warner OC-725C amplifier (Warner Instruments) was used for amplifying GABA-evoked currents that were then filtered and digitised at 10 Hz using the Powerlab 8/35 with LabChart reader version 8.1 (AD Instruments).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation